Pitcairn CO Blueprint Medicines Corp Transaction History

Pitcairn CO

$1.5 Billion
Q2 2025

A detailed history of Pitcairn CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pitcairn CO holds 4,744 shares of BPMC stock, worth $614,158. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,744

Previous 2,314 105.01%

Holding current value

$614,158

Previous $296,000 105.41%

% of portfolio

0.04%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 18, 2025	BUY	$79.22 - $128.4 $192,504 - $312,012	2,430 Added 105.01%	4,744 $608,000
Q2 2025 Aug 14, 2025	SELL	$79.22 - $128.4 $691,828 - $1.12 Million	-8,733 Reduced 79.05%	2,314 $296,000
Q1 2025 May 09, 2025	BUY	$86.69 - $115.63 $38,056 - $50,761	439 Added 4.14%	11,047 $977,000
Q4 2024 Feb 12, 2025	BUY	$82.48 - $101.39 $24,166 - $29,707	293 Added 2.84%	10,608 $925,000
Q3 2024 Nov 12, 2024	BUY	$84.1 - $120.5 $486,350 - $696,851	5,783 Added 127.6%	10,315 $953,000
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $25,383 - $32,416	298 Added 7.04%	4,532 $488,000
Q1 2024 May 13, 2024	SELL	$73.17 - $99.79 $47,853 - $65,262	-654 Reduced 13.38%	4,234 $401,000
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $1,978 - $4,177	45 Added 0.93%	4,888 $450,000
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $12,991 - $18,282	277 Added 6.07%	4,843 $243,000
Q2 2023 Aug 11, 2023	SELL	$42.2 - $66.37 $12,491 - $19,645	-296 Reduced 6.09%	4,566 $288,000
Q1 2023 May 05, 2023	BUY	$37.97 - $50.0 $184,610 - $243,100	4,862 New	4,862 $218,000
Q3 2022 Nov 10, 2022	BUY	$49.93 - $77.7 $168,513 - $262,237	3,375 New	3,375 $222,000
Q2 2022 Aug 12, 2022	SELL	$45.23 - $70.15 $155,862 - $241,736	-3,446 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$54.1 - $110.08 $40,196 - $81,789	-743 Reduced 17.74%	3,446 $220,000
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $118,472 - $145,799	-1,257 Reduced 23.08%	4,189 $449,000
Q3 2021 Nov 10, 2021	SELL	$80.98 - $109.47 $111,752 - $151,068	-1,380 Reduced 20.22%	5,446 $559,000
Q2 2021 Aug 11, 2021	BUY	$82.78 - $101.0 $234,350 - $285,931	2,831 Added 70.86%	6,826 $600,000
Q1 2021 May 10, 2021	BUY	$90.71 - $108.28 $26,487 - $31,617	292 Added 7.89%	3,995 $388,000
Q4 2020 Feb 05, 2021	BUY	$92.08 - $124.48 $16,758 - $22,655	182 Added 5.17%	3,703 $415,000
Q3 2020 Nov 03, 2020	SELL	$66.45 - $92.7 $128,381 - $179,096	-1,932 Reduced 35.43%	3,521 $326,000
Q2 2020 Jul 28, 2020	BUY	$57.09 - $79.27 $311,311 - $432,259	5,453 New	5,453 $425,000

Others Institutions Holding BPMC

# of Institutions

389

Shares Held

66.9M

Call Options Held

973K

Put Options Held

1.54M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account